Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 25 | 2026 | 800 | 3.520 |
Why?
|
| Heart Failure | 22 | 2026 | 2332 | 2.340 |
Why?
|
| Heart-Assist Devices | 17 | 2026 | 1020 | 1.970 |
Why?
|
| Glucosides | 1 | 2025 | 55 | 0.880 |
Why?
|
| Benzhydryl Compounds | 1 | 2025 | 79 | 0.860 |
Why?
|
| Organ Transplantation | 2 | 2026 | 175 | 0.800 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2024 | 176 | 0.790 |
Why?
|
| Heart Defects, Congenital | 7 | 2025 | 1889 | 0.790 |
Why?
|
| Child | 49 | 2026 | 26341 | 0.740 |
Why?
|
| Pulmonary Heart Disease | 1 | 2022 | 4 | 0.720 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2024 | 161 | 0.680 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 79 | 0.670 |
Why?
|
| Hypertension, Pulmonary | 2 | 2025 | 457 | 0.660 |
Why?
|
| Retrospective Studies | 36 | 2026 | 17753 | 0.620 |
Why?
|
| Cardiomyopathies | 6 | 2026 | 514 | 0.610 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 215 | 0.610 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 108 | 0.570 |
Why?
|
| Tracheostomy | 1 | 2020 | 212 | 0.540 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 177 | 0.530 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 315 | 0.520 |
Why?
|
| Graft Rejection | 7 | 2026 | 552 | 0.500 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 259 | 0.490 |
Why?
|
| Clostridium Infections | 1 | 2019 | 250 | 0.470 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 46 | 0.470 |
Why?
|
| Postoperative Complications | 5 | 2026 | 3147 | 0.460 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 108 | 0.450 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1176 | 0.450 |
Why?
|
| Stroke Volume | 2 | 2023 | 541 | 0.420 |
Why?
|
| Adolescent | 23 | 2026 | 20987 | 0.420 |
Why?
|
| Humans | 59 | 2026 | 131163 | 0.410 |
Why?
|
| Child, Preschool | 20 | 2026 | 15110 | 0.380 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 257 | 0.380 |
Why?
|
| Female | 30 | 2026 | 70963 | 0.330 |
Why?
|
| Registries | 4 | 2025 | 1634 | 0.320 |
Why?
|
| Male | 28 | 2026 | 64957 | 0.320 |
Why?
|
| Infant | 15 | 2026 | 13352 | 0.310 |
Why?
|
| Heart Ventricles | 3 | 2025 | 749 | 0.300 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2021 | 140 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2024 | 1064 | 0.260 |
Why?
|
| Central Nervous System Infections | 1 | 2026 | 27 | 0.240 |
Why?
|
| Isoantibodies | 1 | 2026 | 59 | 0.230 |
Why?
|
| Young Adult | 10 | 2026 | 10103 | 0.230 |
Why?
|
| Shock, Cardiogenic | 2 | 2024 | 176 | 0.220 |
Why?
|
| Glutathione Transferase | 1 | 2026 | 148 | 0.220 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2026 | 70 | 0.220 |
Why?
|
| Methylprednisolone | 1 | 2025 | 94 | 0.210 |
Why?
|
| HLA Antigens | 1 | 2026 | 221 | 0.210 |
Why?
|
| Treatment Outcome | 11 | 2025 | 12936 | 0.210 |
Why?
|
| Tetralogy of Fallot | 3 | 2015 | 170 | 0.190 |
Why?
|
| Allografts | 1 | 2024 | 220 | 0.190 |
Why?
|
| Myocarditis | 1 | 2024 | 122 | 0.190 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 45 | 0.190 |
Why?
|
| Hemorrhage | 2 | 2023 | 487 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 301 | 0.180 |
Why?
|
| Echocardiography | 3 | 2025 | 1125 | 0.180 |
Why?
|
| Transplants | 1 | 2022 | 38 | 0.180 |
Why?
|
| Transplant Recipients | 4 | 2026 | 235 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 350 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2024 | 5063 | 0.180 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2024 | 268 | 0.180 |
Why?
|
| Warfarin | 1 | 2023 | 121 | 0.180 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8635 | 0.180 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.170 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 5196 | 0.170 |
Why?
|
| Hemolysis | 1 | 2021 | 86 | 0.170 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 35 | 0.170 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 663 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2021 | 227 | 0.170 |
Why?
|
| Prognosis | 6 | 2024 | 4886 | 0.170 |
Why?
|
| Patient Selection | 1 | 2024 | 729 | 0.160 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2020 | 45 | 0.160 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 187 | 0.160 |
Why?
|
| Heart Rate | 1 | 2023 | 577 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 162 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 259 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2025 | 781 | 0.150 |
Why?
|
| Macrophages | 1 | 2024 | 667 | 0.150 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 133 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2022 | 233 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 214 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 216 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 629 | 0.140 |
Why?
|
| Transposition of Great Vessels | 1 | 2020 | 118 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1103 | 0.140 |
Why?
|
| Overweight | 1 | 2021 | 387 | 0.140 |
Why?
|
| Ventricular Function, Right | 2 | 2025 | 126 | 0.140 |
Why?
|
| Risk Factors | 6 | 2024 | 11074 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2023 | 499 | 0.140 |
Why?
|
| Capillaries | 1 | 2018 | 63 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 255 | 0.130 |
Why?
|
| Heart | 2 | 2022 | 650 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1489 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2022 | 1246 | 0.130 |
Why?
|
| Thrombosis | 1 | 2022 | 499 | 0.130 |
Why?
|
| Length of Stay | 2 | 2020 | 1421 | 0.130 |
Why?
|
| Cardiac Catheterization | 4 | 2025 | 630 | 0.130 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 132 | 0.130 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 361 | 0.120 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 261 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1129 | 0.120 |
Why?
|
| Lung Transplantation | 1 | 2021 | 363 | 0.120 |
Why?
|
| Graft Survival | 3 | 2024 | 465 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 442 | 0.120 |
Why?
|
| Adult | 11 | 2025 | 31282 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2016 | 61 | 0.120 |
Why?
|
| Myocardium | 3 | 2025 | 852 | 0.110 |
Why?
|
| Recurrence | 1 | 2019 | 1489 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1061 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 2825 | 0.110 |
Why?
|
| Hemodynamics | 3 | 2025 | 810 | 0.110 |
Why?
|
| Diastole | 1 | 2015 | 181 | 0.110 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 158 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 705 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 77 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3763 | 0.100 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 279 | 0.100 |
Why?
|
| Cardiac Volume | 1 | 2013 | 17 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 193 | 0.100 |
Why?
|
| Prevalence | 1 | 2020 | 2701 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2015 | 483 | 0.090 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 36 | 0.090 |
Why?
|
| Contrast Media | 1 | 2016 | 474 | 0.090 |
Why?
|
| United States | 3 | 2024 | 12072 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1147 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1826 | 0.090 |
Why?
|
| Survival Rate | 3 | 2025 | 2114 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 29 | 0.090 |
Why?
|
| Waiting Lists | 2 | 2024 | 253 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2200 | 0.070 |
Why?
|
| Hospitalization | 3 | 2024 | 1950 | 0.070 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 549 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2023 | 605 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 963 | 0.060 |
Why?
|
| Obesity | 2 | 2021 | 2426 | 0.060 |
Why?
|
| HLA-DQ Antigens | 1 | 2026 | 21 | 0.060 |
Why?
|
| Heart-Lung Transplantation | 1 | 2024 | 16 | 0.050 |
Why?
|
| Gadolinium | 1 | 2024 | 110 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1168 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 2304 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 365 | 0.050 |
Why?
|
| Time Factors | 2 | 2025 | 6196 | 0.050 |
Why?
|
| Cicatrix | 1 | 2024 | 123 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 50 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2023 | 44 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 28 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 208 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 78 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 97 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 39 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 450 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 31 | 0.040 |
Why?
|
| Antithrombins | 1 | 2022 | 49 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 48 | 0.040 |
Why?
|
| Transferrin | 1 | 2021 | 46 | 0.040 |
Why?
|
| Diuretics | 1 | 2022 | 159 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2021 | 1717 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2021 | 101 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 71 | 0.040 |
Why?
|
| Antibodies | 1 | 2022 | 322 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 355 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 280 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 227 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 208 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 258 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1153 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 398 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 798 | 0.040 |
Why?
|
| Genotype | 1 | 2026 | 2595 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 88 | 0.040 |
Why?
|
| Benchmarking | 1 | 2020 | 137 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1239 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2019 | 3359 | 0.040 |
Why?
|
| Miniaturization | 1 | 2019 | 26 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 401 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1801 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1319 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 482 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 687 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 304 | 0.040 |
Why?
|
| Incidence | 1 | 2026 | 3360 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2021 | 455 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2021 | 506 | 0.030 |
Why?
|
| Sternotomy | 1 | 2018 | 41 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 682 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 216 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 514 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 643 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 807 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 36 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 44 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3711 | 0.030 |
Why?
|
| Aorta | 1 | 2018 | 521 | 0.030 |
Why?
|
| Biomarkers | 1 | 2024 | 3385 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 789 | 0.030 |
Why?
|
| Animals | 2 | 2025 | 33912 | 0.020 |
Why?
|
| Pulmonary Circulation | 1 | 2013 | 113 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 2082 | 0.020 |
Why?
|
| Exercise Test | 1 | 2011 | 239 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 943 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1378 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 18301 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1680 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 28601 | 0.010 |
Why?
|